Prevtec’s research and innovation led to its new bivalent vaccine, Coliprotec® F4/F18 to be approved in record time in the European Union in January 2017. The European Medicines Agency (EMA) states that Coliprotec® F4/F18 has the potential to change the current practice to give antibiotics to control infection in pig herds.
Antimicrobial resistance (AMR) has increasingly been recognised as a growing global health threat (WHO, 2012), and the urgency of the AMR situation is now well accepted by many policy-makers, scientists, as well as by civil society organisations, including patients’ advocacy groups.Source : www.rand.org/randeurope
The World Organisation for Animal Health (OIE), an intergovernmental organisation with 180 members in 2016 has prioritized diseases for which vaccines could reduce antimicrobial use in animals (December 2016). They are focusing as a first step on vaccines for pigs, poultry and fish, aim at identifying actions to improve the utilisation of such vaccines and support the WHO Global Action Plan on AMR.
The “One Health” collaboration between FAO (Food and Agriculture Organization of United Nations), World Organisation for Animal Health and World Health Organization will focus on collaborations and joint priorities including AMR.
In Canada, organizations such as the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) help monitor antimicrobial resistance in humans, livestock and retail meat.